Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture

Abstract

Our data suggest that mifepristone and tamoxifen are effective inducers of apoptosis and may represent nonandrogen-ablation, novel therapeutic approaches to overcome a potential intrinsic apoptosis resistance of androgen-independent prostate cancer cells.